MedTrace Logo

Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms

NCT07570667 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2026-05-06

No results posted yet for this study

Summary

The investigators propose a prospective, longitudinal, observational study to improve health assessment by analyzing blood plasma molecular patterns in each individual over time using artificial intelligence (AI) to identify key measurements for early detection of NCDs. It will develop personalized reference ranges and screening methods, laying the foundation for population-based early detection. This study focus on collecting health data and biospecimen samples to understand early molecular changes linked to disease.

Conditions

Sponsors & Collaborators

  • Center for Molecular Fingerprinting Research Nonprofit LLC

    collaborator UNKNOWN

  • Ludwig-Maximilians - University of Munich

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Dennis KM Ip, MD · School of Public Health, The University of Hong Kong

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2048-05-29
Completion
2048-05-29

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07570667 on ClinicalTrials.gov